Position of the Company and its Subsidiaries (Unit: Baht Million) 30 December 2019 31 December 2018 % Change Cash and cash equivalents 119 103 15.1% Account receivables 737 700 5.3% Inventories 512 885 (42
by THB 62 million. 2. Advance received from customer increased by THB 76 million. 3. Long-term loan from other parties increased by THB 89 million due to weakening of Thai Baht. 4. Provision increased
customer groups of the company and its subsidiaries. The impact therefore greatly affects sales both volume, as well as the sales prices and gross margins of various product groups, which have weakened due
Discussion & Analysis Q1/2022 Operating Highlights in Q1/2022 Q1/21 Q1/22 Change +/(-) (THB million) %YoY Operating Revenue 179 198 11% Gross Profit 105 120 14% EBITDA 57 58 2% Net Profit (Loss) for the
Summary Significant Events Operating Highlights in Q1/2023 Q1/22 Q1/23 Change +/(-) (THB million) %YoY Operating Revenue 198 264 33% Gross Profit 120 168 40% EBITDA 58 80 38% Net Profit (Loss) for the
Significant Event Operating Highlights in Q1/2024 Q1/23 Q1/24 Change +/(-) (THB million) %YoY Operating Revenue 264 340 29% Gross Profit 168 226 35% EBITDA 80 113 41% Net Profit (Loss) for the Company 34 54 59
under trademark “Wuttisak Clinic” the Company has change the business strategy for appropriate with the business environment by closed 7 departments which have accumulate loss in July 2019 and decreased
genuine gross margin in 2017 was at 57.5% for the warehouse rental and service business which decreased from 69.0% last year, mainly due to change in product mix between Built-to-Suit and Ready-built
determine the CPO pricing policy, economic change, and climate change. However, the determined policy and controlling the rate of loss cannot eliminate all the risks, they were just reduced the risks and
distribution 234 351 118 50.4 749 957 208 27.8 Others 23 18 (5) (21.8) 38 43 5 14.3 Total 3,627 3,862 235 6.5 10,582 10,976 394 3.7 For the 3-month period ended Change For the 9-month period ended Change